Williams Kristen Marie's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Feb 3, 2026
- Accession no.
- 0001628280-26-005157
- Filed
- Feb 3, 2026
- Trade date
- Jan 30-Feb 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $269.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williams Kristen MarieCIK 0001296965 | Officer (Chief Administrative Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Common Stock | FTax withholdingDisposed | −17,134 | $20.54 | −$351,932.36 | 144,440 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −13,137 | $20.53 | −$269,702.61 | 131,303 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.